Patent · US Active

Antibody cytokine engrafted compositions and methods of use for immunoregulation

US10144768B2 · kind B2 · utility

0Cited by
6References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 1, 2016
Grant dateDec 4, 2018
Priority date
Expiry dateDec 29, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/31
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides antibody cytokine engrafted proteins that bind to and stimulate intracellular signaling through interleukin 10 receptor. Provided antibody cytokine engrafted proteins find use in enhancing anti-inflammatory cell responses, and reducing pro-inflammatory effects in the treatment, amelioration and prophylaxis of immune related disorders. Additionally provided are polynucleotides and vectors that encode antibody cytokine engrafted proteins and host cells capable of producing antibody cytokine engrafted proteins, as well as methods of combining antibody cytokine engrafted proteins with other therapeutics in treating immune related disorder.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.